etomidate and dezocine
etomidate has been researched along with dezocine in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cheng, Z; Dong, T; Fang, J; Jiang, S; Li, A; Li, F; Liang, B; Lu, Z; Lv, Z; Zhu, J | 1 |
| Chen, H; Ding, Y; He, L; Li, Z; Qian, Y | 1 |
| Bao, Z; Yang, Y; Zhou, C; Zhu, Y | 1 |
Reviews
1 review(s) available for etomidate and dezocine
| Article | Year |
|---|---|
Using dezocine to prevent etomidate-induced myoclonus: a meta-analysis of randomized trials.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Etomidate; Humans; Myoclonus; Randomized Controlled Trials as Topic; Tetrahydronaphthalenes | 2017 |
Trials
2 trial(s) available for etomidate and dezocine
| Article | Year |
|---|---|
Intravenous dezocine pretreatment reduces the incidence and intensity of myoclonus induced by etomidate.
Topics: Administration, Intravenous; Adult; Anesthetics, Intravenous; Bridged Bicyclo Compounds, Heterocyclic; Etomidate; Female; Humans; Incidence; Male; Middle Aged; Myoclonus; Tetrahydronaphthalenes | 2014 |
Dezocine pretreatment prevents myoclonus induced by etomidate: a randomized, double-blinded controlled trial.
Topics: Adult; Aged; Analgesics, Opioid; Anesthesia, General; Bridged Bicyclo Compounds, Heterocyclic; Double-Blind Method; Etomidate; Female; Humans; Hypnotics and Sedatives; Incidence; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Myoclonus; Tetrahydronaphthalenes; Young Adult | 2015 |
Other Studies
1 other study(ies) available for etomidate and dezocine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |